Join NTOCC for the next Lunch N’ Learn webinar:
September 25, 2025
AT 12 PM CDT/1PM EDT
“Postpartum and Beyond: Strategies and Tools
to Facilitate Transitions of Care for Patients with
Hypertensive Disorders of Pregnancy”
Presented by
Ana Safri, PharmD, MBA, BCACP
PGY2 Ambulatory Care
Residency Program Coordinator,
Boston Medical Center
Kara K. Hoppe, DO, MS, PhD, FACOG
Physician, Professor and
Vice Chair of Clinical Research
University of WI-Madison
Kim Soetaert, RN MSN C-EFM
Clinical Operations Specialist, Corwell Health
Klodiana Myftari, PharmD, BCACP
Director of Clinical Improvement Program,
American Medical Association (AMA),
Register Here
SUMMARY:
Hypertensive disorders of pregnancy (HDP) are significant contributors to maternal morbidity and mortality, especially during the early postpartum period. This timeframe includes numerous types of transitions of care, and a team-based approach is essential to maintain continuity of blood pressure monitoring and management between care delivery settings and disciplines. In this session, speakers will share insights on transitions of care considerations during this critical time of birthing persons’ care continuum. Additionally, three different health care systems will share their unique experiences designing and implementing postpartum blood pressure monitoring and management programs. Practical strategies that have helped facilitate and optimize transitions of care will be highlighted, along with specific tools and resources.
Learning Objectives
Describe the complexity of transitions of care during the early postpartum period and potential impact on blood pressure monitoring and management
Review strategies to facilitate and optimize continuity of blood pressure monitoring and management postpartum
Highlight specific tools and resources to facilitate and optimize transitions of care
:SPEAKER BIOS
Ana Safri, PharmD, MBA, BCACP is an ambulatory care clinical pharmacy specialist and the PGY2 Ambulatory Care Residency Program Coordinator at Boston Medical Center. She practices in the outpatient cardiology clinic, where she provides comprehensive care for patients with hypertension, hyperlipidemia, heart failure, and other cardiovascular conditions. Dr. Safri earned her Bachelor of Arts in Educational Studies from Emory University in 2015, her Master of Business Administration from Texas Tech University in 2020, and her Doctor of Pharmacy degree from Texas Tech University Health Sciences Center in 2021. She completed both her PGY1 Pharmacy Practice and PGY2 Ambulatory Care residencies at Boston Medical Center, where she now serves as the PGY2 Ambulatory Care Residency Coordinator.
Kara K. Hoppe, DO, MS, PhD, FACOG is a Professor (CHS) and Vice Chair of Clinical Research in the Department of Obstetrics and Gynecology at the University of Wisconsin School of Medicine and Public Health. A nationally recognized Maternal-Fetal Medicine specialist, Dr. Hoppe leads research focused on maternal cardiovascular health, particularly hypertensive disorders during pregnancy and postpartum. She is the principal investigator of the Staying Healthy After Childbirth (STAC) program, a remote monitoring initiative that has influenced national guidelines. Transition of care is a focus of her groups work with the goal to improve immediate and long-term outcomes for patients with hypertension during pregnancy. Dr. Hoppe has authored over 40 peer-reviewed publications and serves as Core Project PI on a $5 million CDC-funded study to improve hypertension control among Black women and birthing people. She is also a dedicated educator and mentor, committed to advancing health equity through clinical care, research, and community partnerships.
Kim Soetaert, RN MSN C-EFM. As Clinical Operations Specialist at Corewell Health, and former OB Nurse, I bring a deep understanding of patient care and system-level strategy to my work. In my current role, I collaborate with clinical teams to standardize and streamline processes, improving both the patient experience and clinical outcomes. I am passionate about leveraging technology to enhance patient-centered care, and I have successfully led and implemented innovative solutions in areas such as nurse triage and the safe management of postpartum hypertension. My work is driven by a commitment to excellence, safety, and continuous improvement—ensuring that both patients and providers are supported every step of the way.
Klodiana Myftari, PharmD, BCACP, is the Director of Clinical Improvement Program at the American Medical Association (AMA), Dr. Myftari collaborates with healthcare teams nationwide to implement quality improvement (QI) programs focused on cardiovascular disease (CVD) prevention and management. Her emphasis is on developing, implementing, and supporting adaptations of clinical and operational solutions for healthcare networks, organizations, clinics, and pharmacy services. Dr. Myftari advocates for evidence-based prescribing practices that benefit all patient populations. Her work highlights improving medication use through research, education, coaching, and the deployment of team-based care services. With more than 15 years of experience as a clinical pharmacist in academia, pharmacy practice, and leadership roles, she is a pioneer in establishing and evaluating pharmacists’ services in community pharmacies, ambulatory care settings, and population health management.